• Information for Suppliers

    Quality Assurance Policy for Diagnostics Products amended in February 2014

    • QA Policy for Diagnostics Products QA Policy for Diagnostic Products (“QA policy”) as issued on 14 December 2010 amended in February 2014
    • Quality Assurance Policy for DiagnosticsThe Expert Review Panel mechanism Presentation
      download [ PDF - 252 KBEnglish ]
    • Invitation to manufacturers of HIV molecular tests using dried blood spots (conventional and POC) and Diagnostic Technologies for HCV (RDT, EIA and molecular tests) to submit an Expression of Interest (EoI) for product evaluation by an Expert Review Panel for Diagnostics (ERPD) 
      download [ PDF - 417 KBEnglish ]
      Submission deadline: 20 March 2015
    • Expert Review Panel for Diagnostics (ERPD) - Lessons learned from the Pilot round
      download [ PDF - 207 KBEnglish ]
    • ERPD Product questionnaire  
      download [ DOCX - 128 KBEnglish ]
    • Expert Review Panel for Diagnostics-Terms of Reference
      download [ PDF - 158 KBEnglish ]

    Click here for details.

    Quality Assurance Policy for Pharmaceutical Products

    Quality Control Drug Testing Laboratory for Global Fund quality monitoring activities

    Questionnaire on the technical proficiency of QC Drug Testing Laboratories
    download [ DOC - 218 KBEnglish ]

    We are using this information to provide PRs with a List of QC [ XLSX - 92 KBEnglish ] Laboratories meeting Global Fund requirements, along with a list of WHO-prequalified laboratories who have responded to the questionnaire.

    Voluntary Pooled Procurement

    VPP procures through two procurement agents which were competitively selected. The Partnership for Supply Chain Management (PFSCM) procures ARVs; ACTs; rapid diagnostic tests for HIV and malaria; and IRS – and IDA Foundation procures LLINs and other health products: